---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-25-000550"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T01:42:25.797168+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeloc reports FY2024 net loss of $1.05M on revenue down 8% to $8.54M

## Summary
- Net loss of $1.053M ($0.41 diluted EPS) vs net profit of $205.6K ($0.08 EPS) in 2023.
- Revenue declined 8% to $8.538M from $9.330M; gross margin fell to 40.4% from 43.3%.
- Record R&D investment in SpinDx drug detection; beta testing of THC disk in Q2 2025, commercial launch early 2026.
- Closed $750K debenture in Dec 2024 plus $75K in Q1 2025 to fund SpinDx development.

## SEC filing metadata
- accession: 0001079973-25-000550
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997325000550/0001079973-25-000550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997325000550/lctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-25-000550
- JSON: https://secwatch.observer/filing/0001079973-25-000550.json
- Plain text: https://secwatch.observer/filing/0001079973-25-000550.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.